Good research pointing out discrepancy/poor communication one the excellagen front ..... just another example of how this company is not operating in its own universe and to date has not shown it has executed or can execute on any promises or initiatives.... it provides no numbers for sales, grants, loans, nor does it provide numbers for vendor debts, lawsuits, administrative expenses, studies or clinical trials. For a holding company, this is absolutely insane. Even numbers in red might suggest it is advancing on some front.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links